Bruce Rehlaender

Bruce has over 30 years of experience in formulation, drug delivery technologies and drug product manufacturing. As a Principal with PharmaDirections, he designs and oversees development of novel drug products, specializing in controlled release technologies and solubilization of poorly soluble drugs. He develops and utilizes computer models to analyze pharmacokinetic data and predicts ideal drug product characteristics. He also manages the manufacturing of clinical trial materials and prepares documents for regulatory submission.